CJC + IPA Blend (CJC-1295 + Ipamorelin) — Research Material
CJC + IPA Blend — CJC-1295 + Ipamorelin
CJC + IPA is a co-lyophilized research blend of CJC-1295 without DAC (5 mg) and Ipamorelin (5 mg).
HPLC-verified at ≥99% purity with a batch-specific certificate of analysis on every lot.
Purity ≥99% HPLC
VIAL 10 MG (5+5)
COA Per lot
Shipping US · 2-day
Per vial, with 20% Fall Sale discount already applied.
Choose quantity
What is in the CJC + IPA blend
CJC + IPA pairs two peptides that are normally studied separately — CJC-1295 (without DAC) and
Ipamorelin — co-lyophilized in a single 10 mg vial at 5 mg each.
CJC-1295 without DAC is a GRF/GHRH analog (also called Mod GRF 1-29; CAS 863288-34-0). Ipamorelin is a selective growth hormone secretagogue pentapeptide (CAS 170851-70-4). The two are structurally unrelated and act through different
mechanisms, which is why they are studied as a pair rather than as a single molecule.
Co-lyophilisation matters practically: both peptides reconstitute from one vial in one step, so
the ratio between them is fixed at manufacture rather than by pipetting two separate stocks. Nothing
on this page should be read as a claim that the combination produces any particular result.
Blend components
CJC-1295 (no DAC)
A GRF/GHRH analog (Mod GRF 1-29). CAS 863288-34-0. Supplied here at 5 mg per vial, HPLC-verified to ≥99%.
Ipamorelin
A selective growth hormone secretagogue pentapeptide. CAS 170851-70-4. Supplied here at 5 mg per vial, HPLC-verified to ≥99%.
CJC + IPA: published literature
The references below concern the individual components, not this blend. Both
peptides have been studied principally in laboratory and animal models; neither is an approved
drug, and the CJC-1295 + Ipamorelin combination has not been evaluated as a combination in published
clinical trials. They are cited as literature — APEX 100 Research makes no claim about
outcomes, efficacy or suitability for any purpose.
J Clin Endocrinol Metab, 2006 · PMID 16352683
Buy CJC + IPA (CJC-1295 + Ipamorelin)
Volume pricing applies automatically at checkout.
Prices shown include the 20% Fall Sale discount.
Common questions
What is in the CJC + IPA blend?
One 10 mg vial containing CJC-1295 without DAC (5 mg) and Ipamorelin (5 mg), co-lyophilized together. Catalogue
SKU A100-CP10.
What does ≥99% HPLC purity mean?
High-performance liquid chromatography separates the sample into its components and measures each
as a proportion of the total. ≥99% means the target peptide accounts for at least 99% of the
material by that method. The chromatogram showing this is included in the lot’s COA.
Can I see the COA before ordering?
Yes. Sample documentation is on our COA page, and we will send the specific
COA for any lot on request — before or after purchase.
Is this a drug product?
No. This material is supplied strictly as a research material. It is not a drug product and is
not for human consumption.
How is this shipped?
Sourced and shipped within the United States, typically 2-day delivery. Lyophilized peptides are
stable in transit; refrigerate on arrival.
Why are both peptides in one vial?
They are co-lyophilized, so the 5 mg : 5 mg ratio is fixed at manufacture and both reconstitute
in a single step. It removes the pipetting error involved in combining two separate stocks.
CJC + IPA Purity & COA
Every lot is tested before release and ships with its own certificate of analysis. We publish the
COA unredacted — including the lot number, the test date and the actual chromatogram — rather than
a summary figure.
HPLC purity
High-performance liquid chromatography establishes purity against the ≥99% specification.
The chromatogram is included in the COA, not just the resulting number.
Mass spectrometry
Identity is confirmed by mass spectrometry against the expected molecular weight of each component (CJC-1295 without DAC ~3367.9 g/mol, Ipamorelin 711.9 g/mol).
Lot traceability
Each vial’s lot number corresponds to a specific COA on file. Request the document for any
lot you have received at any time.
CJC + IPA Specifications
| Blend | CJC + IPA — CJC-1295 (no DAC) 5 mg + Ipamorelin 5 mg, co-lyophilized (10 mg total) |
|---|---|
| Component 1 | CJC-1295 without DAC (Mod GRF 1-29) — GRF/GHRH analog |
| CJC-1295 CAS | 863288-34-0 |
| CJC-1295 formula | C152H252N44O42 |
| CJC-1295 molecular weight | 3367.9 g/mol |
| Component 2 | Ipamorelin — pentapeptide growth hormone secretagogue |
| Ipamorelin CAS | 170851-70-4 |
| Ipamorelin formula | C38H49N9O5 |
| Ipamorelin molecular weight | 711.9 g/mol |
| Physical form | Lyophilized powder, white to off-white |
| Purity | ≥99% by HPLC, per component |
| Identity confirmation | Mass spectrometry |
| Vial size | 10 mg (SKU A100-CP10) |
| Storage | Lyophilized: 36–46 °F. Long term: −4 °F, protected from light |
| Documentation | Batch-specific COA, unredacted, retained on file per lot |
Handling and storage
Supplied lyophilized. Standard laboratory handling for peptides of this class applies.
| Lyophilized storage | 36–46 °F short term; −4 °F for extended storage, protected from light |
|---|---|
| Reconstitution | Bacteriostatic water is the common choice for laboratory reconstitution. Add solvent slowly against the vial wall; do not inject directly onto the powder. |
| Mixing | Swirl gently until dissolved. Do not shake or vortex — mechanical agitation can shear peptide chains. |
| After reconstitution | Refrigerate at 36–46 °F. Avoid repeated freeze-thaw cycles. |
| Light | Protect from light at all stages. |
These are general laboratory handling notes for a lyophilized peptide. They are not a protocol,
and nothing on this page constitutes a dosing recommendation of any kind.
All materials supplied by APEX 100 Research are intended exclusively for laboratory research by
qualified professionals. They are not drugs, foods, cosmetics, or medical devices, and they are
not intended to diagnose, treat, cure or prevent any disease or condition.
Nothing on this page is medical advice, a dosing recommendation, or a representation that this
compound is safe or effective for any purpose. CJC + IPA is an investigational compound that
has not been approved for any use by the FDA or any comparable regulatory authority. Peer-reviewed
publications are referenced above so researchers may consult the primary literature directly;
their citation is not a claim about this material.
By purchasing, the buyer confirms they are a qualified researcher, are 21 years of age or older,
and accept full responsibility for lawful handling, storage and use of the material.
